Source: Australian Therapeutic Goods Administration
This consultation closes on Wednesday, 26 March 2021.
The Therapeutic Goods Administration (TGA) has received a number of enquiries relating to residual activity claims for disinfectants, including whether statements can be made for disinfectants such as ‘residual activity for up to 30 days’, and what testing methods should be used to provide evidence for these claims.
At present, there is no definition of “residual activity” included in the Therapeutic Goods (Standard for Disinfectants and Sanitary Products) (TGO 104) 2019 (the Order) or the TGA published guidance document: TGA Instructions for Disinfectant Testing. There are also no defined test methods or specified acceptance criteria for such testing. To date, claims have been considered (and continue to be considered) by the TGA assessors on a case by case basis.
We invite you to review the consultation paper Proposal for clarifying regulatory requirements for residual claims for disinfectants and provide a response using our online survey, both of which are accessible through our consultation hub. We appreciate all views, so if you would prefer to respond by email or written document, you can find further details on the hub.
Feedback from the Consultation Paper may inform changes to the regulatory framework, including the TGO 104 or other accompanying documentation relating to disinfectants.